Data / Drug companies / Alcon Laboratories, Inc.
Alcon Laboratories, Inc.: 50 products in the FDA NDC directory, labeler code 0065
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Alcon Laboratories, Inc. (labeler code 0065) lists 50 products in the FDA National Drug Code Directory, covering 26 finished drugs by generic name. By type: 32 over the counter drugs, 18 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 16, 2026.
The request: Watch Alcon Laboratories, Inc. (FDA labeler code 0065): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0065
- Products in commercial distribution
- 50
- Packages
- 93
- Finished drugs by generic name
- 26
- Prescription products
- 18
- Over the counter products
- 32
- Flagged as original packager
- 48 of 48 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- June 30, 1958
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 26 | 52% |
| New drug applications (NDA) | 19 | 38% |
| Generic drugs (ANDA) | 5 | 10% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 32 | 64% |
| Prescription drugs | 18 | 36% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Polyethylene glycol 400 and propylene glycol | 8 | 2 |
| Propylene glycol | 6 | 5 |
| Olopatadine hydrochloride | 3 | 35 |
| Cyclopentolate hydrochloride | 3 | 3 |
| Dextran, hypromellose | 2 | 1 |
| Hypromellose | 2 | 3 |
| Atropine sulfate | 2 | 24 |
| Phenylephrine hydrochloride | 2 | 77 |
| Polyethylene glycol and propylene glycol | 1 | 2 |
| Polyethylene glycol 400, propylene glycol 0.3% | 1 | 1 |
| Mineral oil and white petrolatum | 1 | 1 |
| Fluorescein | 1 | 8 |
| Povidone-iodine | 1 | 58 |
| Mineral oil, white petrolatum | 1 | 3 |
| Propylene glycol emulsion | 1 | 1 |
| Acoltremon | 1 | 1 |
| Apraclonidine hydrochloride | 1 | 1 |
| Dextran 70, glycerin, hypromellose | 1 | 2 |
| Dextran 70, hypromellose 2910 | 1 | 1 |
| Cyclopentolate hydrochloride and phenylephrine hydrochloride | 1 | 1 |
| Brinzolamide/brimonidine tartrate | 1 | 1 |
| Tetracaine hydrochloride | 1 | 9 |
| Naphazoline hydrochloride and pheniramine maleate | 1 | 5 |
| Carbachol | 1 | 1 |
| Hypromellose 2910 | 1 | 1 |
| Ketotifen fumarate | 1 | 19 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution/ drops | 20 | 40% |
| Solution | 12 | 24% |
| Emulsion | 7 | 14% |
| Gel | 4 | 8% |
| Kit | 3 | 6% |
| Ointment | 2 | 4% |
| Injection, solution | 1 | 2% |
| Suspension/ drops | 1 | 2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Brytly | 0065-8596 | Solution/ drops | New drug applications (NDA) | October 16, 2026 |
| Systane Complete PF | 0065-2509 | Emulsion | Over the counter monograph drugs | November 1, 2025 |
| Tryptyr | 0065-8595 | Solution | New drug applications (NDA) | July 23, 2025 |
| Systane Pro PF | 0065-9308 | Emulsion | Over the counter monograph drugs | March 14, 2025 |
| Systane Pro PF | 0065-3290 | Emulsion | Over the counter monograph drugs | January 31, 2025 |
| Bion tears | 0065-9305 | Solution/ drops | Over the counter monograph drugs | April 1, 2023 |
| Atropine sulfate | 0065-0817 | Solution | New drug applications (NDA) | November 1, 2022 |
| Alcon Tears Lubricant Eye Drops | 0065-0408 | Solution/ drops | Over the counter monograph drugs | March 1, 2022 |
| Systane Ultra Preservative Free | 0065-1507 | Solution/ drops | Over the counter monograph drugs | February 15, 2022 |
| Systane COMPLETE PF | 0065-1530 | Emulsion | Over the counter monograph drugs | February 1, 2022 |
| Systane COMPLETE PF | 0065-1509 | Emulsion | Over the counter monograph drugs | January 18, 2022 |
| GenTeal Tears Gel Drops | 0065-8067 | Gel | Over the counter monograph drugs | February 4, 2021 |
| Systane hydration pf preservative free | 0065-1510 | Solution/ drops | Over the counter monograph drugs | February 1, 2021 |
| Pataday once daily relief | 0065-0816 | Solution | New drug applications (NDA) | September 1, 2020 |
| Pataday once daily relief | 0065-8150 | Solution | New drug applications (NDA) | February 28, 2020 |
| Pataday twice a day relief | 0065-4274 | Solution | New drug applications (NDA) | February 25, 2020 |
| Systane hydration pf preservative free | 0065-1437 | Solution/ drops | Over the counter monograph drugs | February 1, 2020 |
| GenTeal Tears Severe | 0065-8064 | Gel | Over the counter monograph drugs | December 31, 2019 |
| GenTeal Tears NIGHT-TIME | 0065-0518 | Ointment | Over the counter monograph drugs | September 5, 2019 |
| Isopto Atropine | 0065-0303 | Solution | New drug applications (NDA) | August 1, 2018 |
| GenTeal Tears Moderate Preservative Free | 0065-8063 | Solution/ drops | Over the counter monograph drugs | July 3, 2018 |
| Systane COMPLETE | 0065-0481 | Emulsion | Over the counter monograph drugs | January 18, 2018 |
| Systane Day and Night Value Pack | 0065-1502 | Kit | Over the counter monograph drugs | October 24, 2017 |
| Tetracaine Hydrochloride | 0065-0741 | Solution | New drug applications (NDA) | November 2, 2016 |
| GenTeal Tears (Moderate) | 0065-0426 | Solution/ drops | Over the counter monograph drugs | March 1, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.